Powerlifting Athlete Suspended for the Presence of Methandienone and Methylphenidate

Ottawa – May 13, 2022 – The Canadian Centre for Ethics in Sport (CCES) announced today that Jessica Pietrzyk, a powerlifting athlete, received a four-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on February 12, 2022, revealed the presence of methandienone (a prohibited anabolic agent) and methylphenidate (a prohibited specified stimulant).

Because Ms. Pietrzyk failed to dispute the anti-doping rule violation within the timelines specified in the Canadian Anti-Doping Program (CADP), the violation, sanction, and all proposed consequences were confirmed by way of a deemed waiver. A sanction of four years was imposed, which terminates on April 3, 2026.

During the sanction period, the athlete, who resides in Edmonton, Alberta, is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates.

In compliance with rule 8.4 of the CADP, the CCES’s file outcome summary can be found in the Canadian Sport Sanction Registry.

About the CCES

The Canadian Centre for Ethics in Sport works collaboratively to ensure Canadians have a positive sport experience. Through its programs, the CCES manages unethical issues in sport, protects the integrity of Canadian sport, and promotes True Sport to activate values-based sport on and off the field of play. The CCES is an independent, national, not-for profit organization that is responsible for the administration of the Canadian Anti-Doping Program (CADP). Under the CADP rules, the CCES makes public every anti-doping rule violation. The CCES acknowledges funding, in part, from the Government of Canada. For more information, visit cces.ca, follow us on Twitter, Facebook, or Instagram

 

--30--

For further information, please contact:

+1 613-521-3340 x3233
[email protected]

See Also...

Canadian Anti-Doping Program

The 2021 Canadian Anti-Doping Program came into effect on January 1, 2021, ensuring the program’s ongoing compliance with the World Anti-Doping Code.